Join to access to all OVN content. Join for Free
Season 2, Episode 6: Mentorship and Career Growth with Josh Schwartz

Season 2, Episode 6: Mentorship and Career Growth with Josh Schwartz


Share This Article


Welcome back to another fantastic episode of the Pharmaverse podcast!

This week our host Michael Pietrack interviews Josh Schwartz, MD MBA, Vice President of Medical Affairs North America at BeOne ( formerly BeiGene.) They discuss the importance of leadership in the pharmaceutical industry, focusing on developing others, the journey from individual contributor to manager, and the qualities that make an effective leader. Schwartz shares insights on mentorship, the coaching tree concept, and the five Cs of leadership: caring, communication, culture, challenge, and career development. He emphasizes the significance of treating people well, being authentic, and continuously seeking feedback to grow as a leader. Tune in for a great episode on Leadership, Mentorship and career growth with a phenomenal Pharma leader.

Takeaways 🔑

👌Developing other people is crucial for leadership.

📈The journey from individual contributor to manager can be rapid if the opportunity arises.

👀Observing both good and bad leaders provides valuable lessons.

💞Caring and communication are foundational to effective leadership.

🤝Creating a supportive culture is essential for team success.

📚 Career development should be a priori ty for leaders.

👨‍🏫 Mentorship can significantly impact career growth.

📑A good mentor is a mentor for life. 

🎉Hiring non-traditional leaders can bring fresh perspectives.

💪Aspiring leaders should treat people well, be themselves, and work hard.

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Article
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
OVN Avatar Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved
OVN Avatar Sean X Zhang, MSc , Dean Fergusson, PhD , Jonathan Kimmelman, PhD

Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved

Explore OVN